论文部分内容阅读
近年来,肝癌早期检出率明显上升,手术率上升。肝切除术是治疗肝癌的重要方法,对于直径<5 cm的单个肝癌,5年生存率在50.0%以上;直径<2 cm的肝癌,5年生存率为60.0%~80.0%,肝癌切除术5年复发率为60.0%~80.0%。肝癌术后复发的诊治效果均不够理想,循环肿瘤细胞检测等新技术的应用,为复发肝癌的早期诊断创造了条件,也为再手术
In recent years, the early detection rate of liver cancer increased significantly, the operation rate increased. Hepatectomy is an important method for the treatment of liver cancer. The 5-year survival rate is above 50.0% for single hepatocellular carcinoma <5 cm in diameter, and the 5-year survival rate is 60.0% -80.0% for hepatocellular carcinoma <2 cm in diameter. Hepatectomy 5 The annual recurrence rate was 60.0% ~ 80.0%. The diagnosis and treatment of postoperative recurrence of liver cancer are not ideal, the application of new technologies such as circulating tumor cells test for the early diagnosis of recurrent liver cancer, but also for reoperation